PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
-1.66%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.8B
AUM Growth
+$1.8B
(-14%)
Cap. Flow
-$111M
Cap. Flow
% of AUM
-6.19%
Top 10 Holdings %
Top 10 Hldgs %
74.06%
Holding
48
New
1
Increased
18
Reduced
7
Closed
5
Top Buys
| 1 |
CEMP
Cempra, Inc.
CEMP
|
$36.6M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$15.4M |
| 3 |
Amicus Therapeutics
FOLD
|
$15.3M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
$8.74M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$5.64M |
Top Sells
| 1 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
$84.4M |
| 2 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$44.3M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$34.5M |
| 4 |
THOR
THORATEC CORPORATION
THOR
|
$17M |
| 5 |
Intuitive Surgical
ISRG
|
$13.4M |
Sector Composition
| 1 | Healthcare | 77.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $261M | 14.52% | 2,889,505 +62,500 | +2% | +$5.64M |
|
|
ANAC
2
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $247M | 13.75% | 2,187,242 -391,912 | -15% | -$44.3M |
|
3
United Therapeutics
UTHR
$13.8B
| $238M | 13.24% | 1,518,654 -5,600 | -0.4% | -$877K |
|
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $140M | 7.79% | 1,336,847 -329,645 | -20% | -$34.5M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $124M | 6.91% | 3,547,719 +438,911 | +14% | +$15.4M |
|
6
Insmed
INSM
$28.8B
| $87M | 4.84% | 4,790,800 +22,000 | +0.5% | +$399K |
|
|
AMAG
7
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $85.6M | 4.77% | 2,835,792 +58,400 | +2% | +$1.76M |
|
|
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
| $51.6M | 2.87% | 2,132,157 +75,906 | +4% | +$1.84M |
|
|
ENDP
9
DELISTED
Endo International plc
ENDP
| $49.1M | 2.73% | 801,230 | – | – |
|
10
Prothena Corp
PRTA
$441M
| $47.4M | 2.64% | 695,518 -400 | -0.1% | -$27.2K |
|
|
EPZM
11
DELISTED
Epizyme, Inc
EPZM
| $42.6M | 2.37% | 2,660,979 +545,341 | +26% | +$8.74M |
|
12
Karyopharm Therapeutics
KPTI
$61.7M
| $41.2M | 2.3% | 3,112,645 +26,900 | +0.9% | +$356K |
|
13
Vanda Pharmaceuticals
VNDA
$279M
| $37.5M | 2.09% | 4,030,908 +33,800 | +0.8% | +$315K |
|
|
CEMP
14
DELISTED
Cempra, Inc.
CEMP
| $36.6M | 2.04% | +1,175,733 | New | +$36.6M |
|
|
15
Amicus Therapeutics
FOLD
$2.34B
| $34.4M | 1.92% | 3,551,173 +1,576,797 | +80% | +$15.3M |
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $32.4M | 1.81% | 270,800 | – | – |
|
17
Gilead Sciences
GILD
$140B
| $30.7M | 1.71% | 302,900 -14,000 | -4% | -$1.42M |
|
|
MDVN
18
DELISTED
MEDIVATION, INC.
MDVN
| $24.6M | 1.37% | 509,862 | – | – |
|
|
MNTA
19
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $21.8M | 1.21% | 1,468,776 +13,600 | +0.9% | +$202K |
|
|
SHPG
20
DELISTED
Shire pic
SHPG
| $21.5M | 1.19% | 104,700 | – | – |
|
21
STAAR Surgical
STAA
$1.36B
| $19M | 1.06% | 2,666,722 +23,800 | +0.9% | +$170K |
|
|
SQNM
22
DELISTED
SEQUENOM INC NEW
SQNM
| $16.4M | 0.92% | 10,023,842 | – | – |
|
|
ZLTQ
23
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $16.4M | 0.91% | 573,636 +5,200 | +0.9% | +$148K |
|
24
Rigel Pharmaceuticals
RIGL
$697M
| $15.9M | 0.88% | 5,239,119 +62,800 | +1% | +$190K |
|
|
ARIA
25
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $14.1M | 0.79% | 2,257,217 +25,500 | +1% | +$159K |
|